Medytox Holds Launch Symposium for HA Filler 'Neuramis' in Saudi Arabia

Medytox announced on the 5th that it held a launch symposium for the hyaluronic acid (HA) filler 'Neuramis' in Riyadh and Jeddah, Saudi Arabia, on the 1st and 2nd (local time) of this month.

On the 1st and 2nd (local time), at the 'Newramis' launch symposium held in Saudi Arabia, plastic surgeon Dr. Noh Hyung-joo is giving a lecture to local dermatologists.
[Photo by Medytox]

Medytox received product approval for Neuramis from the Saudi Food and Drug Authority (SFDA) in April, conducted local product testing, and began sales last month.

The event was held for about 200 local dermatologists in Saudi Arabia. Dr. Hyungjoo Noh, a plastic surgery specialist from Healthpoint Hospital in Abu Dhabi, United Arab Emirates, attended as a speaker and introduced the efficacy of Neuramis and the botulinum toxin product 'Medytoxyn' (export name: Siacks) based on his clinical experience.

Saudi Arabia is a Middle Eastern country with a population of approximately 37 million and has the largest economy among the Gulf Cooperation Council (GCC) countries. According to the market research firm Euromonitor, the beauty market size reached $6.3 billion (about 8 trillion KRW) last year.

Medytox plans to expand Neuramis' market share through collaboration with its local partner, Amico Group. At the same time, the company aims to leverage the brand recognition built through Medytoxyn locally to grow Neuramis into the representative filler in Saudi Arabia.

Yonggi Oh, Director of Medytox's Overseas Business Team, said, "Our goal is to achieve a 30% market share in the filler market within three years by establishing a customized local marketing strategy together with Amico Group, which has a strong sales network in Saudi Arabia and the Middle East. We are also promoting the construction of a local production plant in Dubai based on the non-animal liquid toxin product 'MT10109L.' Taking the successful entry of Neuramis into the Saudi market as an opportunity, we will accelerate our expansion into the Middle East."

Neuramis is an HA filler independently developed by Medytox in 2013, which enhances durability by improving the efficiency of the hyaluronic acid cross-linking reaction.

This content was produced with the assistance of AI translation services.